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Vascular smooth muscle cell (VSMC) proliferation is a key
event in the progression of arteriosclerosis. Clinical studies
show that uremic toxins deteriorate the arteriosclerosis in
renal failure patients. Indoxyl sulfate (IS) is a strong
protein-bound uremic toxin, but the effect of IS on VSMC
proliferation has not been studied. We examined the effect
of IS on rat VSMC proliferation, assessed by a cell counting
kit (4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,
3-benzene disulfonate] assay) and by [3H]thymidine
incorporation in vitro. We further evaluated a contribution of
mitogen-activated protein kinase (MAPK; p44/42 MAPK) to
VSMC proliferation by IS. Immunohistochemical staining was
performed for VSMCs using antirat organic anion transporter
(OAT)3 antibody. The mRNA expressions of platelet-derived
growth factor (PDGF)-A and -C chains, and PDGF-b receptor
were evaluated by real-time PCR. IS stimulated the
proliferation of VSMCs in a concentration-dependent manner
and activated p44/42 MAPK. Concentration of IS needed to
stimulate the proliferation of rat VSMC was about 250 lM,
which is compatible with that in the serum of end-stage renal
failure patients. PD98059 (10 lM), a selective inhibitor of
MAPK/extracellular signal-regulated kinase, inhibited the
IS-induced (250 lM) VSMC proliferation and phosphorylation
of MAPK. Probenecid (0.5 mM), an inhibitor and substrate of
OAT, inhibited the IS-induced (250 lM) VSMC proliferation.
Rat OAT3 was detected in VSMCs. The mRNA expressions
of PDGF-C chain and PDGF-b receptor were significantly
increased by IS. We conclude that IS directly stimulates rat
VSMC proliferation and activates MAPK in vitro. This might
be one of the mechanisms underlying the progression of
atherosclerotic lesions in end-stage renal disease patients.
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Improvements in dialysis treatment have resulted in prolon-
gation of the survival period of hemodialysis patients, but
their prognosis is still poor compared to that in the general
population.1 The major cause of death in patients under-
going dialysis is cardiovascular disease.2 The pathophysiology
of cardiovascular disease in end-stage renal disease patients is
not completely understood; however, accumulation of
uremic toxins that are difficult to be removed from the body
by current dialysis procedures is partly involved in the
condition.3,4 Indoxyl sulfate (IS) is one of the organic anions
metabolized in the liver from indole, which is produced by
the intestinal bacteria as a metabolite of tryptophan.5
Although the molecular weight of IS is small, the rate of
binding to albumin is high in the blood,6 which, in turn,
leads to its large secretion from the proximal tubule cells in
urine.7 Various organic anion transporters (OATs) exist in
proximal tubules, and it has recently been revealed that IS is
secreted in urine mainly by OAT3, one of the members of the
OAT family.8 Therefore, IS accumulates in the body of
patients with reduced renal function.5
Removal of IS by hemodialysis is difficult because the size
of the IS–albumin complex molecule in blood is larger than
the pore size of a dialysis membrane.5 Thus, IS is considered
to be one of the main uremic toxins that are difficult to be
removed from the body by current dialysis procedures.5 It has
been reported that IS accelerates the progression of renal
failure,9 but only one datum is available about the effects of
IS on the cardiovascular system.10
In the progression of atherosclerotic lesions, the prolifera-
tion of vascular smooth muscle cells (VSMCs) is of particular
importance. The mitogen-activated protein kinase (MAPK)
cascades are a well-documented family of serine/threonine
kinases that include p44/42 MAPK (also called extracellular
signal-regulated kinases (ERK1/2)), p38 MAPK, and c-Jun
N-terminal kinase.11 The p44/42 MAPK cascade is the most
well characterized and is shown to mediate proliferative
responses in various cells, including mesangial cells12 and
VSMCs.13 Growth factors, such as platelet-derived growth
factor (PDGF),14 angiotensin II,15 erythropoietin,16 and
uremic toxins such as homocysteine,17 and uric acid18 can
activate intracellular signaling cascades, leading to the
proliferation of VSMCs. However, the effects of IS on VSMC
proliferation and activation of MAPK have not been studied.
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In this study, we therefore directly investigated the effects
of IS in vitro on VSMC proliferation and MAPK activation
using cultured rat VSMCs.
RESULTS
IS increases rat VSMC proliferation and DNA synthesis
First, we examined the effect of IS on the number of VSMCs.
IS significantly increased the number of VSMCs in a con-
centration-dependent manner (Figure 1). PDGF (10 ng/ml)
also increased the number of VSMCs.
We next evaluated whether the increase in cell prolifera-
tion was accompanied with DNA synthesis. Figure 2a shows
that [3H]thymidine incorporation was also significantly
increased by IS (100–500 mM). Because IS is mainly bound
to albumin in the serum, we also evaluated the effect of IS in
the presence of 4 g/dl albumin in the medium. Although
basal value was significantly lower with albumin, IS at 250
and 500 mM significantly increased the uptake (Figure 2b).
This result indicates that IS stimulated VSMC proliferation
even in the presence of 4 g/dl albumin. IS in the body is made
from tryptophan in the intestine5 and the medium used in
this study contained tryptophan (78 mM), which may affect
the results. Thus, we further examined the effect of the
removal of tryptophan from the medium. As shown in
Figure 3, 250 mM IS increased the [3H]thymidine incorpora-
tion by VSMCs in both the presence and absence of
tryptophan (78 mM). Therefore, IS, but not its precursor,
directly stimulated the proliferation of VSMC in vitro.
As IS is reported to be the substrate of OAT3 in the
proximal tubule cell membrane,8 we next examined whether
the proliferation of VSMCs is mediated by cellular transport
of IS via the OAT. As shown in Figure 4, the increase of
[3H]thymidine incorporation in VSMCs by 250 mM IS was
partly prevented by co-administration of 0.5 mM probenecid,
an inhibitor and substrate of OAT,8 whereas probenecid alone
did not affect it. Next, to determine whether OAT3 is present
in rat VSMCs, we performed immunostaining of rat VSMCs
by rat OAT3 antibody. As shown in Figure 5, the rat VSMCs
had strong signals of rat OAT3, mainly in the cell membrane.
IS activates the p44/42MAPK pathway in rat VSMCs
To evaluate further intracellular signaling event in the effects
of IS on the rat VSMC proliferation, we investigated the
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Figure 1 | Effect of IS on the proliferation of rat VSMCs by
4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene
disulfonate] proliferation assay. Growth-arrested VSMCs were
stimulated by IS and PDGF for 24 h. 4-[3-[4-lodophenyl]-
2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene disulfonate] was
added for the last 4 h. PDGF (10 ng/ml) was used as a positive control.
Absorbance was measured by an enzyme-linked immunosorbent
assay reader. Values are mean7s.e.m. (n¼ 8). *Po0.05 compared
with the vehicle.
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Figure 2 | Effect of IS on the proliferation of rat VSMCs assessed
by DNA synthesis. (a) Growth-arrested VSMCs were stimulated by IS
and PDGF for 24 h. [3H]Thymidine was added for the last 6 h. PDGF
(10 ng/ml) was used as a positive control. (b) Effect of IS on the
proliferation of rat VSMCs in the presence of 4 g/dl albumin in the
medium assessed by DNA synthesis. Values are mean7s.e.m. (n¼ 8).
*Po0.05 compared with the vehicle.
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Figure 3 | Effect of the removal of tryptophan on IS-induced
increase of DNA synthesis in rat VSMCs. Growth-arrested VSMCs
were incubated for 24 h in DMEM or tryptophan () medium with or
without IS (250mM). [3H]Thymidine was added for the last 6 h. Values
are mean7s.e.m. (n¼ 8). *Po0.05 compared with vehicle.
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activation of p44/42 MAPK in VSMCs. As plasma concen-
tration of IS in hemodialysis patients is reported to be about
250 mM,5 we selected this dose for the following experiments.
IS at 250 mM induced p44/42 MAPK phosphorylation in
the cells, with a maximal intensity at 5 min (Figure 6). To
confirm that the p44/42 MAPK pathway was actually
involved in the IS-induced mitogenesis, we pretreated
VSMCs with 10 mM PD98059, an MAPK/ERK kinase
inhibitor,14 to inhibit the pathway. The IS-induced
phosphorylation was significantly inhibited by PD98059
(Figure 7). We further evaluated the effect of pretreatment
with PD98059 at the same dose on the increase in IS-induced
[3H]thymidine incorporation. PD98059 inhibited the
increase in DNA synthesis by IS, whereas PD98059 alone
had no effect on DNA synthesis (Figure 8).
IS increases mRNA expressions of PDGF-C chain and PDGF-b
receptor
To discuss the mechanisms of IS-induced proliferation of
VSMC, we evaluated the mRNA expressions of PDGF-A and
-C chains, and PDGF-b receptor by real-time PCR. We found
that mRNA expressions of PDGF-C chain and PDGF-b
receptor were significantly increased by the addition of IS
(Figure 9). Therefore, the increased expressions by IS are
partly involved in the mechanism of IS-induced VSMC
proliferation.
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Figure 4 | Effect of probenecid on IS-induced increase of DNA
synthesis in rat VSMC. Growth-arrested VSMCs were pretreated for
1 h with probenecid (0.5 mM) and then stimulated by IS (250mM) for
24 h. Values are mean7s.e.m. (n¼ 8). *Po0.05.
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Figure 5 | Immunohistochemistry of rat OAT3 in rat VSMCs.
(a) VSMCs were stained with polyclonal antibodies against rat OAT3
(b) There was no staining in the negative control with rabbit
immunoglobulin fraction. Bar¼ 200mm.
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Figure 6 | Effect of IS on p44/42 MAPK phosphorylation.
Growth-arrested VSMCs were stimulated by IS (250mM) for the
indicated times. (a) Representative immunoblots are shown with
antibodies that recognize phosphorylated p44/42 MAPK and total
p44/42 MAPK. (b) Densitometric analysis of phosphorylated p44/42
MAPK. Values are mean7s.e.m. (n¼ 5). *Po0.05.
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Figure 7 | Effect of PD98059 on IS-induced phosphorylation of
p44/42 MAPK. Growth-arrested VSMCs were pretreated with
PD98059 (10mM) for 1 h and then stimulated by IS (250 mM) for 5 min.
(a) Representative immunoblots are shown with antibodies that
recognize phosphorylated p44/42 MAPK and total p44/42 MAPK.
(b) Densitometric analysis of phosphorylated p44/42 MAPK. Values
are mean7s.e.m. (n¼ 5). *Po0.05.
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Figure 8 | Effect of PD98059 on IS-induced proliferation of rat
VSMCs assessed by DNA synthesis. Growth-arrested VSMCs were
pretreated for 1 h with PD98059 (10 mM) and then stimulated with IS
(250 mM) for 24 h. Values are mean7s.e.m. (n¼ 8). *Po0.05.
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DISCUSSION
It is known that IS is a protein-bound uremic toxin that
accelerates the progression of renal failure,5 but data are
limited about its actions on other organs. A recent in vitro
study has shown that IS has a suppressive effect on the repair
of damage in human umbilical vein endothelial cells,
suggesting that the agent is involved in endothelium
dysfunction in renal failure.10 The present study shows for
the first time that IS directly promotes VSMC proliferation.
This is the most important finding in the present study.
Serum concentration of IS in patients with end-stage renal
failure is about 250 mM,5 which is compatible with that
needed to stimulate the proliferation of rat VSMCs in this
study. As the enhanced proliferation of VSMCs in vascular
walls is believed to promote hypertrophy of arteries, it is
possible that VSMC proliferation induced by IS is one of the
causes of cardiovascular complications that occur in dialysis
patients with a high serum IS.
As IS is known to be transported by OATs on tubular cell
membranes, the effect of probenecid, an inhibitor and
substrate of OATs, on VSMC proliferation was investigated.
In this experiment, we found that probenecid had an
inhibitory effect on the proliferation of VSMCs. We also
confirmed the presence of OAT3 in VSMCs by immunostain-
ing. These findings suggest that IS is at least in part taken into
VSMCs via OAT. Proliferation of VSMCs plays some role in
the development of hypertension and arteriosclerosis,19 and
the p44/42 MAPK pathway is thought to be the intracellular
signaling pathway involved in the proliferation of VSMCs.13
When we evaluated the involvement of MAPK in the effect of
IS on VSMCs, we found that pretreatment of VSMCs with
PD98059, an inhibitor of MAPK, caused inhibition of VSMC
proliferation. We also found that IS induced p44/42 MAPK
phosphorylation, which was inhibited by PD98059. These
findings indicate that the p44/42 MAPK pathway is involved
in the induction of VSMC proliferation by IS.
In the present study, serum was not used in experiments
examining the effects of IS stimulation, although no
significant difference was found between the degrees of
VSMC proliferation in serum with and without IS (data not
shown). However, serum contains various growth factors,
some of which might have a strong proliferative effect
in addition to IS on VSMCs. Indeed, we found that the
mRNA expressions of PDGF-C chain and PDGF-b receptor
were increased by IS. Therefore, the increased expressions
by IS are partly involved in the mechanism of IS-induced
VSMC proliferation. The culture medium used in the
present study contained tryptophan, a precursor of IS,
but the possibility that the presence of tryptophan in the
medium affected the results was ruled out by comparison of
results of experiments using a medium containing trypto-
phan and a medium from which tryptophan had been
removed.
The mechanisms by which IS induces proliferation of
VSMC and activation of MAPK are not known. Uric acid has
also been reported to be a uremic toxin that induces
proliferation of VSMCs. Rao et al.18 reported that uric acid
induces proliferation of VSMCs by promoting the produc-
tion of PDGF-A chain, and Johnson et al.20,21 reported that
uric acid is taken up by VSMCs via an OAT. As a potential
mechanism for VSMC proliferation, uric acid, after being
taken into VSMCs, activates MAPK and induces the
production of cyclooxygenase-2 and the expression of
PDGF-A chain, -C chain, and PDGF-a receptor mRNA.20
We found that the induction of VSMC proliferation by IS
was inhibited by probenecid and that MAPK was involved
in the induction of VSMC proliferation by IS. Therefore,
the mechanism of IS-induced VSMC proliferation might be
similar to that of uric acid. To our knowledge, other protein-
bound uremic toxins that have been shown to induce VSMC
proliferation in vitro are homocysteine22 and leptin.23 Further
study is needed to determine whether MAPK activation by
IS is mediated by various growth factor receptors on the
cell membrane surface or by an as yet unidentified receptor.
To understand the pathophysiology of cardiovascular disease
in end-stage renal disease patients, the effect of IS on other
cell types of blood vessels and their crosstalk must be
evaluated in the future.
In summary, the present in vitro study shows for the first
time that IS directly induces cell proliferation of rat VSMC.
Concentration of IS required to induce VSMC proliferation is
similar to its blood concentration in patients on maintenance
dialysis. Part of the action of IS on VSMC is mediated by
OAT3, and the induction of VSMC proliferation by MAPK
activation caused by IS. Increases of mRNA expressions
of PDGF-C chain and PDGF-b receptor are also involved in
the phenomenon. This might be one of the mechanisms
underlying the progression of atherosclerotic lesions in
end-stage renal disease patients.
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Figure 9 | Effect of IS on mRNA expressions of PDGF-A and -C
chains and PDGF-b receptor. Growth-arrested VSMCs were stimu-
lated with IS (250 mM) for 6 h and then total RNA was isolated.
Real-time quantitative PCR was performed as described in Materials
and Methods. Values are mean7s.e.m. of two identical samples
performed in at least triplicate (n¼ 4 in each). *Po0.05 compared
with the vehicle.
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MATERIALS AND METHODS
Materials
A p44/42 MAPK assay kit, including anti-p44/42 MAP kinase and
anti-phospho-p44/42 MAP kinase (Thr202/Try204) antibodies, was
purchased from Cell Signaling Technology (Beverly, MA, USA).
A Cell Counting Kit was purchased from DOJINDO Laboratories
(Kumamoto, Japan). [3H]Thymidine was purchased from Perkin
Elmer Life Science (Boston, MA, USA). Anti-rat OAT3 polyclonal
antibody was purchased from TransGenic Inc. (Kumamoto, Japan).
All other materials including IS were purchased from Sigma
(St Louis, MO, USA). IS was dissolved with distilled water as
vehicle in all experiments.
Cell culture
VSMCs were isolated from the aortas of male Sprague–Dawley rats
(150–200 g) as previously described.13 In brief, VSMCs were
maintained in Dulbecco’s modified Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) (ICN Biomedi-
cals, Osaka, Japan), 100 U/ml penicillin, and 100 mg/ml streptomy-
cin (Life Technology Inc., Rockville, MD, USA) in a 5% CO2
incubator at 371C. VSMCs at 70–80% confluence were growth-
arrested by incubation in DMEM with 0.5% FBS for 48 h. The cells
were used between passages 3 and 8. VSMCs were identified by their
typical hill and valley morphology and by indirect immunofluor-
escent staining for a-smooth muscle actin (R&D Systems Inc.,
Minneapolis, MN, USA). We measured endotoxin concentration in
the medium by limulus amebocyte lysate method (Wako Pure
Chemical Industries, Osaka, Japan) and found that it was under the
detection limit, which strongly indicated the absence of lipopoly-
saccharide in the medium.
Cell proliferation assay
VSMC proliferation was assessed using the Cell Counting Kit.24 The
cells were seeded at a density of 5 103 cells/well on 96-well culture
plates in DMEM with 10% FBS for 72 h. After serum starvation for
48 h in DMEM with 0.5% FBS, the cells were stimulated by IS or
PDGF as a positive control for 24 h. For the final 4 h of incubation,
4-[3-[4-lodophenyl]-2-4(4-nitrophenyl)-2H-5-tetrazolio-1,3-benzene
disulfonate] was added to each well and the absorbance was measured
at 450 nm with a reference wavelength of 650 nm using a microplate
spectrophotometer system (SOFTmax PRO, Molecular Devices
Corporation, Sunnyvale, CA, USA). The difference of absorbance
between 450 and 650 nm was regarded as the cell proliferation.
[3H]Thymidine incorporation
The cells were seeded on 24-well culture plates, allowed to grow to
70–80% confluence, and then growth-arrested by incubation in
DMEM with 0.5% FBS for 48 h. The cells were incubated for 24 h,
and [3H]thymidine (1mCi/ml; specific activity, 79 Ci/mmol) was
added to for the last 6 h of the incubation period. The cells were then
washed three times with phosphate-buffered saline, treated with ice-
cold 10% trichloroacetic acid at 41C for 15 min, and washed with
phosphate-buffered saline. The acid-insoluble material was dissolved
in 0.5 ml of 0.3 N NaOH. The protein content was measured by a DC
Protein Assay (Bio-Rad, Hercules, CA, USA), and radioactivity was
determined by using a liquid scintillation counter (Aloka, Japan).
Western blot analysis
Growth-arrested cells cultured in 100-mm dishes were stimulated by
250mM IS for the indicated times. For the inhibitor studies, cells
were pretreated for 1 h with PD98059 (10 mM), an MAPK/ERK
kinase inhibitor.14 The cells were washed with ice-cold phosphate-
buffered saline and lysed in 400 ml of lysis buffer (1% Triton,
20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM
ethyleneglycol tetraacetate, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerophosphate, 1 mM Na3VO4, 1mg/ml L-leupeptin, 1 mM phenyl-
methylsulfonyl fluoride) for 30 min at 41C. The cell lysates were
centrifuged for 15 min at 15 000 g and the supernatants were
collected. Equal amounts of protein (20 mg) were separated by 10%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and
electrophoretically transferred to polyvinylidine difluoride mem-
branes (Invitrogen Corp., Carlsbad, CA, USA). The membranes were
blocked for 1 h at room temperature with Tris-buffered saline
containing 0.05% Tween 20 (TBS-T) and 5% bovine serum
albumin. After washing with TBS-T, the membranes were incubated
overnight with phospho-p44/42 MAPK (Thr202/Tyr204) antibody
(1:1000) or p44/42 MAPK antibody (1:1000) (Cell Signaling
Technology, Beverly, MA, USA) at 41C with gentle shaking. The
primary antibodies were detected using horseradish peroxidase-
conjugated goat antirabbit IgG and visualized by enhanced
chemiluminescence Western blotting reagents (Amersham Bios-
ciences, Buckinghamshire, UK). Band intensity was analyzed using
KODAK 1D Image Analysis Software (KODAK, Rochester, NY,
USA).
Immunohistochemical staining
Immunostaining of OAT3 in rat VSMCs was performed by the
labeled streptavidin biotin (LSAB) method using a DAKO LSAB Kit
(Dako, Carpinteria, CA, USA). Briefly, VSMCs were cultured on
eight-well Lab-Tek chamber slides (Nalge Nunc International) and
fixed with paraformaldehyde lysine periodate solution (containing
0.01 M NaIO4, 0.075 M lysine, 0.0375 M phosphate buffer with 2%
paraformaldehyde; pH 6.2) for 1 h at 41C. After fixation, the cells
were permeabilized in 0.1% Triton X-100 in phosphate-buffered
saline for 5 min and incubated with 3% hydrogen peroxide for
30 min to suppress endogenous peroxidase activity and then with
blocking solution for 10 min. The cells were incubated with a
polyclonal antibody against rat OAT38 (1:20) at 41C overnight. The
negative controls were treated with the rabbit immunoglobulin
fraction (Dako, Carpinteria, CA, USA). After rinsing with TBS-T,
the cells were incubated with a biotinylated link antibody against
rabbit immunoglobulin for 30 min. The cells were washed with TBS-
T and incubated with horseradish peroxidase-conjugated streptavi-
dine solution for 30 min. Horseradish peroxidase labeling was
detected using a peroxidase substrate diaminobenzidine, and then
counterstaining was performed with hematoxylin.
RNA extraction and real-time quantitative PCR
The isolation of total RNA was achieved using the RNeasy Mini Kit
(Quiagen, Valencia, CA, USA). Reverse transcription was performed
with 1.2 mg of total RNA, random hexamer primers, and RevertAid
M-MuLV reverse transcriptase (Fermentas, Hanover, MD, USA).
The resulting cDNA equivalent to 60 ng of RNA was used for real-
time quantitative PCR in the ABI Prism 7700 sequence detection
system (Applied Biosystems, Foster City, CA, USA) as previously
described.25 All of the specific sets of primers and TaqMan probes in
the present study were obtained from Applied Biosystems (Assays-on-
Demand Gene Expression Products and TaqMan Rodent GAPDH
Control Reagants). All primer sets but that of TaqMan Rodent
GAPDH Control Reagents were designed to be located
in two exons to avoid amplification of potentially contaminating
1784 Kidney International (2006) 69, 1780–1785
o r i g i n a l a r t i c l e H Yamamoto et al.: Indoxyl sulfate stimulates VSMC proliferation
genomic DNA. To control the variation in the amount of DNA
available for PCR in the different samples, gene expressions of the
target sequence were normalized in relation to the expression of an
endogenous control, glyceraldehyde-3-phosphate dehydrogenase. As
the efficiency of the target amplification was approximately equal to
that of the glyceraldehyde-3-phosphate dehydrogenase amplifica-
tion, data were analyzed using the comparative threshold cycle
method.26 Because the intra- and interassay coefficients of variation
of the relative expression values were o20%, we considered the
mean relative values of less than 0.8 or more than 1.2 to be
significant in this study.
Statistics
The results are expressed as the mean7s.e.m. Data were analyzed by
the unpaired Student’s t-test or by one-way analysis of variance
combined with Fisher’s protected least significant difference using
personal computer with StatView version 5.0 (SAS Institute,
Cary, NC, USA). Differences with Po0.05 were considered to be
significant.
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